The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
On-body Injectors-Global Market Insights and Sales Trends 2024
Synopsis
An on-body Injector is a small, lightweight delivery system applied to the skin.
The global On-body Injectors market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of On-body Injectors in various end use industries. The expanding demands from the Immuno-oncology, Diabetes, Cardiovascular Diseases and Others, are propelling On-body Injectors market. Electronical Injectors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Mechanical Injectors segment is estimated at % CAGR for the next seven-year period.
The North American region is expected to account for the largest market share in 2018. The large share of this region can be attributed to the rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases and favorable reimbursement scenario in this region.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for On-body Injectors, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global On-body Injectors market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global On-body Injectors market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, On-body Injectors sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of On-body Injectors covered in this report include BD Medical, Medtronic, Insulet, Sensile Medical, Ypsomed, Enable Injections, Roche, ScPharmaceuticals and SteadyMed, etc.
The global On-body Injectors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BD Medical
Medtronic
Insulet
Sensile Medical
Ypsomed
Enable Injections
Roche
ScPharmaceuticals
SteadyMed
CeQur
Tandem Diabetes Care
Valeritas
SteadyMed Therapeutics
Amgen
Global On-body Injectors market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global On-body Injectors market, Segment by Type:
Electronical Injectors
Mechanical Injectors
Others
Global On-body Injectors market, by Application
Immuno-oncology
Diabetes
Cardiovascular Diseases
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of On-body Injectors manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of On-body Injectors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
An on-body Injector is a small, lightweight delivery system applied to the skin.
The global On-body Injectors market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of On-body Injectors in various end use industries. The expanding demands from the Immuno-oncology, Diabetes, Cardiovascular Diseases and Others, are propelling On-body Injectors market. Electronical Injectors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Mechanical Injectors segment is estimated at % CAGR for the next seven-year period.
The North American region is expected to account for the largest market share in 2018. The large share of this region can be attributed to the rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases and favorable reimbursement scenario in this region.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for On-body Injectors, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global On-body Injectors market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global On-body Injectors market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, On-body Injectors sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of On-body Injectors covered in this report include BD Medical, Medtronic, Insulet, Sensile Medical, Ypsomed, Enable Injections, Roche, ScPharmaceuticals and SteadyMed, etc.
The global On-body Injectors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BD Medical
Medtronic
Insulet
Sensile Medical
Ypsomed
Enable Injections
Roche
ScPharmaceuticals
SteadyMed
CeQur
Tandem Diabetes Care
Valeritas
SteadyMed Therapeutics
Amgen
Global On-body Injectors market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global On-body Injectors market, Segment by Type:
Electronical Injectors
Mechanical Injectors
Others
Global On-body Injectors market, by Application
Immuno-oncology
Diabetes
Cardiovascular Diseases
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of On-body Injectors manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of On-body Injectors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 On-body Injectors Market Overview
1.1 On-body Injectors Product Overview
1.2 On-body Injectors Market Segment by Type
1.2.1 Electronical Injectors
1.2.2 Mechanical Injectors
1.2.3 Others
1.3 Global On-body Injectors Market Size by Type
1.3.1 Global On-body Injectors Market Size Overview by Type (2018-2029)
1.3.2 Global On-body Injectors Historic Market Size Review by Type (2018-2023)
1.3.3 Global On-body Injectors Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America On-body Injectors Sales Breakdown by Type (2018-2023)
1.4.2 Europe On-body Injectors Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific On-body Injectors Sales Breakdown by Type (2018-2023)
1.4.4 Latin America On-body Injectors Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa On-body Injectors Sales Breakdown by Type (2018-2023)
2 Global On-body Injectors Market Competition by Company
2.1 Global Top Players by On-body Injectors Sales (2018-2023)
2.2 Global Top Players by On-body Injectors Revenue (2018-2023)
2.3 Global Top Players by On-body Injectors Price (2018-2023)
2.4 Global Top Manufacturers On-body Injectors Manufacturing Base Distribution, Sales Area, Product Type
2.5 On-body Injectors Market Competitive Situation and Trends
2.5.1 On-body Injectors Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by On-body Injectors Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in On-body Injectors as of 2022)
2.7 Date of Key Manufacturers Enter into On-body Injectors Market
2.8 Key Manufacturers On-body Injectors Product Offered
2.9 Mergers & Acquisitions, Expansion
3 On-body Injectors Status and Outlook by Region
3.1 Global On-body Injectors Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global On-body Injectors Historic Market Size by Region
3.2.1 Global On-body Injectors Sales in Volume by Region (2018-2023)
3.2.2 Global On-body Injectors Sales in Value by Region (2018-2023)
3.2.3 Global On-body Injectors Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global On-body Injectors Forecasted Market Size by Region
3.3.1 Global On-body Injectors Sales in Volume by Region (2024-2029)
3.3.2 Global On-body Injectors Sales in Value by Region (2024-2029)
3.3.3 Global On-body Injectors Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global On-body Injectors by Application
4.1 On-body Injectors Market Segment by Application
4.1.1 Immuno-oncology
4.1.2 Diabetes
4.1.3 Cardiovascular Diseases
4.1.4 Others
4.2 Global On-body Injectors Market Size by Application
4.2.1 Global On-body Injectors Market Size Overview by Application (2018-2029)
4.2.2 Global On-body Injectors Historic Market Size Review by Application (2018-2023)
4.2.3 Global On-body Injectors Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America On-body Injectors Sales Breakdown by Application (2018-2023)
4.3.2 Europe On-body Injectors Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific On-body Injectors Sales Breakdown by Application (2018-2023)
4.3.4 Latin America On-body Injectors Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa On-body Injectors Sales Breakdown by Application (2018-2023)
5 North America On-body Injectors by Country
5.1 North America On-body Injectors Historic Market Size by Country
5.1.1 North America On-body Injectors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America On-body Injectors Sales in Volume by Country (2018-2023)
5.1.3 North America On-body Injectors Sales in Value by Country (2018-2023)
5.2 North America On-body Injectors Forecasted Market Size by Country
5.2.1 North America On-body Injectors Sales in Volume by Country (2024-2029)
5.2.2 North America On-body Injectors Sales in Value by Country (2024-2029)
6 Europe On-body Injectors by Country
6.1 Europe On-body Injectors Historic Market Size by Country
6.1.1 Europe On-body Injectors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe On-body Injectors Sales in Volume by Country (2018-2023)
6.1.3 Europe On-body Injectors Sales in Value by Country (2018-2023)
6.2 Europe On-body Injectors Forecasted Market Size by Country
6.2.1 Europe On-body Injectors Sales in Volume by Country (2024-2029)
6.2.2 Europe On-body Injectors Sales in Value by Country (2024-2029)
7 Asia-Pacific On-body Injectors by Region
7.1 Asia-Pacific On-body Injectors Historic Market Size by Region
7.1.1 Asia-Pacific On-body Injectors Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific On-body Injectors Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific On-body Injectors Sales in Value by Region (2018-2023)
7.2 Asia-Pacific On-body Injectors Forecasted Market Size by Region
7.2.1 Asia-Pacific On-body Injectors Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific On-body Injectors Sales in Value by Region (2024-2029)
8 Latin America On-body Injectors by Country
8.1 Latin America On-body Injectors Historic Market Size by Country
8.1.1 Latin America On-body Injectors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America On-body Injectors Sales in Volume by Country (2018-2023)
8.1.3 Latin America On-body Injectors Sales in Value by Country (2018-2023)
8.2 Latin America On-body Injectors Forecasted Market Size by Country
8.2.1 Latin America On-body Injectors Sales in Volume by Country (2024-2029)
8.2.2 Latin America On-body Injectors Sales in Value by Country (2024-2029)
9 Middle East and Africa On-body Injectors by Country
9.1 Middle East and Africa On-body Injectors Historic Market Size by Country
9.1.1 Middle East and Africa On-body Injectors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa On-body Injectors Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa On-body Injectors Sales in Value by Country (2018-2023)
9.2 Middle East and Africa On-body Injectors Forecasted Market Size by Country
9.2.1 Middle East and Africa On-body Injectors Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa On-body Injectors Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 BD Medical
10.1.1 BD Medical Company Information
10.1.2 BD Medical Introduction and Business Overview
10.1.3 BD Medical On-body Injectors Sales, Revenue and Gross Margin (2018-2023)
10.1.4 BD Medical On-body Injectors Products Offered
10.1.5 BD Medical Recent Development
10.2 Medtronic
10.2.1 Medtronic Company Information
10.2.2 Medtronic Introduction and Business Overview
10.2.3 Medtronic On-body Injectors Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Medtronic On-body Injectors Products Offered
10.2.5 Medtronic Recent Development
10.3 Insulet
10.3.1 Insulet Company Information
10.3.2 Insulet Introduction and Business Overview
10.3.3 Insulet On-body Injectors Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Insulet On-body Injectors Products Offered
10.3.5 Insulet Recent Development
10.4 Sensile Medical
10.4.1 Sensile Medical Company Information
10.4.2 Sensile Medical Introduction and Business Overview
10.4.3 Sensile Medical On-body Injectors Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sensile Medical On-body Injectors Products Offered
10.4.5 Sensile Medical Recent Development
10.5 Ypsomed
10.5.1 Ypsomed Company Information
10.5.2 Ypsomed Introduction and Business Overview
10.5.3 Ypsomed On-body Injectors Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Ypsomed On-body Injectors Products Offered
10.5.5 Ypsomed Recent Development
10.6 Enable Injections
10.6.1 Enable Injections Company Information
10.6.2 Enable Injections Introduction and Business Overview
10.6.3 Enable Injections On-body Injectors Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Enable Injections On-body Injectors Products Offered
10.6.5 Enable Injections Recent Development
10.7 Roche
10.7.1 Roche Company Information
10.7.2 Roche Introduction and Business Overview
10.7.3 Roche On-body Injectors Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Roche On-body Injectors Products Offered
10.7.5 Roche Recent Development
10.8 ScPharmaceuticals
10.8.1 ScPharmaceuticals Company Information
10.8.2 ScPharmaceuticals Introduction and Business Overview
10.8.3 ScPharmaceuticals On-body Injectors Sales, Revenue and Gross Margin (2018-2023)
10.8.4 ScPharmaceuticals On-body Injectors Products Offered
10.8.5 ScPharmaceuticals Recent Development
10.9 SteadyMed
10.9.1 SteadyMed Company Information
10.9.2 SteadyMed Introduction and Business Overview
10.9.3 SteadyMed On-body Injectors Sales, Revenue and Gross Margin (2018-2023)
10.9.4 SteadyMed On-body Injectors Products Offered
10.9.5 SteadyMed Recent Development
10.10 CeQur
10.10.1 CeQur Company Information
10.10.2 CeQur Introduction and Business Overview
10.10.3 CeQur On-body Injectors Sales, Revenue and Gross Margin (2018-2023)
10.10.4 CeQur On-body Injectors Products Offered
10.10.5 CeQur Recent Development
10.11 Tandem Diabetes Care
10.11.1 Tandem Diabetes Care Company Information
10.11.2 Tandem Diabetes Care Introduction and Business Overview
10.11.3 Tandem Diabetes Care On-body Injectors Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Tandem Diabetes Care On-body Injectors Products Offered
10.11.5 Tandem Diabetes Care Recent Development
10.12 Valeritas
10.12.1 Valeritas Company Information
10.12.2 Valeritas Introduction and Business Overview
10.12.3 Valeritas On-body Injectors Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Valeritas On-body Injectors Products Offered
10.12.5 Valeritas Recent Development
10.13 SteadyMed Therapeutics
10.13.1 SteadyMed Therapeutics Company Information
10.13.2 SteadyMed Therapeutics Introduction and Business Overview
10.13.3 SteadyMed Therapeutics On-body Injectors Sales, Revenue and Gross Margin (2018-2023)
10.13.4 SteadyMed Therapeutics On-body Injectors Products Offered
10.13.5 SteadyMed Therapeutics Recent Development
10.14 Amgen
10.14.1 Amgen Company Information
10.14.2 Amgen Introduction and Business Overview
10.14.3 Amgen On-body Injectors Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Amgen On-body Injectors Products Offered
10.14.5 Amgen Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 On-body Injectors Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 On-body Injectors Industrial Chain Analysis
11.4 On-body Injectors Market Dynamics
11.4.1 On-body Injectors Industry Trends
11.4.2 On-body Injectors Market Drivers
11.4.3 On-body Injectors Market Challenges
11.4.4 On-body Injectors Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 On-body Injectors Distributors
12.3 On-body Injectors Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
